Achieve Life Sciences
ACHV
16 hedge funds and large institutions have $11.7M invested in Achieve Life Sciences in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 8 closing their positions.
192% more capital invested
Capital invested by funds: $3.99M → $11.7M (+$7.67M)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
2.76% more ownership
Funds ownership: 13.62% → 16.38% (+2.8%)
0% more funds holding
Funds holding: 16 → 16 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.19M |
| 2 |
SC
Shay Capital
New York
|
+$1.6M |
| 3 |
Morgan Stanley
New York
|
+$1.04M |
| 4 |
LPL Financial
San Diego,
California
|
+$628K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$348K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Skylands Capital
Milwaukee,
Wisconsin
|
-$223K |
| 2 |
HR
Hayden Royal
Charlotte,
North Carolina
|
-$181K |
| 3 |
Millennium Management
New York
|
-$162K |
| 4 |
Goldman Sachs
New York
|
-$88K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$85K |
ACHV Hedge Fund Activity: Q1 2021 in Review
16 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2021, worth a combined $11.7M — up 192% from $3.99M a quarter earlier.
Fund positioning in ACHV was balanced in Q1 2021: 8 funds opened new positions, 8 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.19M. The largest seller was Skylands Capital, exiting entirely with an estimated $223K sold.
- 16 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $11.7M of Achieve Life Sciences stock for Q1 2021, up 192% quarter-over-quarter.
- 8 funds opened new Achieve Life Sciences positions in Q1 2021 and 8 closed out, a net change of 0 holders.
- The largest Achieve Life Sciences buyer in Q1 2021 was Vanguard Group, an estimated $3.19M added.
- The largest Achieve Life Sciences seller in Q1 2021 was Skylands Capital, an estimated $223K sold.
Based on aggregated 13F filings for Q1 2021.